Transcript Preliminary classification of proposals by the CEWG ppt, 463kb

7th European Congress of Tropical Medicine and International Health (ECTMIH)
Barcelona 2011
Preliminary classification of proposals by the CEWG
Proposals for innovative financing: Discussing the work to-date of WHO’S Consultative
Expert Working Group on Research and Development: Financing and Coordination (CEWG)
Albrecht Jahn, Institute of Public Health, University of Heidelberg
on behalf of the CEWG members from the European Region
Criteria for evaluation of R&D Financing and Coordination Mechanisms
•
•
•
•
•
•
•
•
•
public health impact in developing countries
rational and equitable use of resources/efficiency considerations
cost-effectiveness
technical feasibility, scaling-up potential, replicability, speed of implementation
financial feasibility and sustainability
additionality
intellectual property management issues
potential for de-linking research and development costs and the price of products
equity/distributive effect, including availability and affordability and impact
on access and delivery
• accountability/participation in governance and decision-making
• impact on capacity building in, and transfer of technology to, developing countries
• potential synergy with other mechanisms/potential for combining with others.
Criteria for evaluation of R&D Financing and Coordination Mechanisms:
Example for milestone and end prizes:
Criterion
Degree Met
Comment

If incorporated in prize design
Technical feasibility

Commonly used in diverse fields
Financial feasibility

Need not be expensive
Intellectual property

If incorporated in prize design
De-linking

If incorporated in prize design
Access

If incorporated in prize design
Public health impact
Efficiency
Cost-effectiveness
Additionality
Accountability
Capacity building

Synergy

Preliminary summary of assessments
Proposals meeting most criteria:
 Patent/IP pools (UNITAID model)
 Open source, open/non-exclusive/equitable licenses
 precompetitive R&D platforms
 Direct grants to SMEs in LMICs
 Prizes (in particular milestones)
1/3
Preliminary summary of assessments
2/4
Proposals meeting fewer criteria:








Tax breaks, orphan drug like legislation (for countries to consider)
Data exclusivity policies – pros and cons
Green IP (a new indirect tax)
Priority review voucher, transferable IPR
Health Impact Fund – need pilot to examine value based rewards
(health impact)
Advance procurement agreements (AMC)
Regulatory harmonization
Reduction of patents’ duration
Preliminary summary of assessments
3/4
Proposals meeting most criteria, but where CEWG need to
do more work




R&D treaty/a global framework for R&D
Pooling of funds (e.g. for PDPs)
Sources of funding (taxes, voluntary contributions etc)
Coordination (regional networks e.g. ANDI)
Preliminary summary of assessments
4/4
Some Preliminary Recommendations:


CEWG intends to recommend strengthening global financing
and coordination mechanisms for R&D for health needs of
developing countries under the auspices of WHO
CEWG intends to recommend that formal intergovernmental
negotiations begin for a binding global instrument for R&D
and innovation for health
Next Steps
 First full draft of summaries of assessments by Sept 2011
 Small group meeting to discuss summaries of




assessments and to discuss content and outline of the
CEWG report
Input from regional consultations presented
at 3rd meeting of the group in November 2011
(Email for further inputs: [email protected])
Discussion of a draft report at the 3rd meeting
Finalization of the draft report after the 3rd meeting
Submission of final report to the WHA in 2012
Thank your for your attention!
Acknowledgment:
The CEWG members
The CEWG secretariat at WHO